Logo

Insight Genetics

Oncocyte to Acquire Insight Genetics for $12M

Insight's portfolio includes a gene expression-based immuno-oncology assay for therapy response prediction.

New Products Posted to GenomeWeb: Thermo Fisher Scientific, Insight Genetics, Allele Biotech

Insight Genetics Raises $3M in Private Offering

The company is developing molecular cancer diagnostics, including a test designed to monitor therapy resistance in non-small cell lung cancer patients.

Biocept, Insight Genetics to Collaborate on Lung Cancer Molecular Diagnostic

The deal centers around ALK, a gene involved in signal transduction and a therapeutic target for non-small cell lung cancer.

People in the News: New WaferGen Execs, Nanosphere Board Member, Insight Genetics Scientists
Premium

WaferGen Biosystems said this week that it has appointed Keith Warner as chief operating officer and Michael Henighan as CFO.
Aug 7, 2014

People in the News: Asuragen, Exosome Name New CEOs; McComb Joins Bio-Rad Board; More
Premium

Mar 6, 2014

German Team Details RT-qPCR Assay to Detect ALK Rearrangements from FFPE
Premium

Mar 3, 2014

Insight Genetics, Vanderbilt-Ingram Aim to ID Novel Rx Response Markers in TNBC

Jan 7, 2014

Insight Genetics Snags $1.5M NCI Award for NSCLC Assay

Dec 13, 2013

In Brief This Week: Veracyte; Danaher; Insight Genetics; Quest Diagnostics; RayBiotech; Biomatrica, Cambio; Seahorse Bioscience

Dec 12, 2013

Dx Focus: Insight Genetics Launches CLIA-Certified Lab
Premium

Oct 3, 2013

Insight Genetics Licenses Bone Marrow Transplant MDx from St. Jude Children's
Premium

Sep 30, 2013

Insight Genetics Licenses St. Jude's Test for Bone Marrow Transplants

Aug 26, 2013

NCI Awards Insight Genetics $1.5M to Further Develop NSCLC Assay

Aug 14, 2013

People in the News: David Burg, Bernhard Sixt, Nicolas Pasqual
Premium

Aug 8, 2013

People in the News: Hologic Promotions; New Hires at Insight Genetics
Premium

Apr 10, 2013

Insight's PCR-Based ALK Test Development Moves Forward with NCI's Help
Premium

Apr 4, 2013

Dx Focus: Insight Genetics Chosen for NCI Clinical Assay Development Program
Premium

Apr 3, 2013

Insight Genetics to Participate in NCI's Program to Move Assays to Clinical Trials

Jan 9, 2013

MDx/CDx Focus: Verastem, LabCorp Ink CDx Pact; Foundation Medicine Raises More Cash; and more
Premium

Nov 12, 2012

NCI Awards Contracts to Insight Genetics to Develop NSCLC CDx

Oct 11, 2012

Insight Genetics Wins $1.5M Grant to Begin Clinical Testing for ALK Mutation CDx on Qiagen Platform
Premium

Jun 1, 2012

Kindstar to Offer Insight Genetics' ALK Lung Cancer Screening Test

May 31, 2012

Clarient Licenses Biomarker IP from Insight Genetics

Jan 10, 2012

Qiagen Gains Approval in Japan for EGFR Companion Dx, Acquires Rights to New Markers